Health
100 Most Popular
Therapy
CRISPR
$49.249876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$49.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.74 (1.53%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell CRISPR and other stocks, options, ETFs, and crypto commission-free!
About CRSP
CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. Read More The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.
Employees
188
Headquarters
Zug, Zug
Founded
2014
Market Cap
2.55B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
379.92K
High Today
$49.61
Low Today
$48.03
Open Price
$48.56
Volume
421.65K
52 Week High
$61.97
52 Week Low
$22.22
Collections
Health
100 Most Popular
Therapy
Biotechnology
Medical
Technology
2016 IPO
CRSP News
Price Paid on Robinhood
18% Higher
Right Now
52 Week Low
$22.22
Average Price Paid
$41.89
52 Week High
$73.90
Analyst Ratings
57%
of 14 ratings
Buy
57%
Hold
29%
Sell
14%
CRSP Earnings
-$1.07
-$0.71
-$0.36
$0.00
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jul 29, After Hours